Scryb Grants Stock Options

Rhea-AI Summary

Scryb (OTC:SCYRF) has announced the granting of 3,870,000 stock options to various company stakeholders. The options are exercisable at $0.12 per share for a five-year period, with 2,910,000 options allocated to directors and officers.

The options fall under the Company's Omnibus Long-Term Incentive Plan and include a four-month and one-day resale restriction. The company utilized exemptions from valuation and minority shareholder approval requirements under MI 61-101 for the insider participation portion.

News Market Reaction

-4.05%

1 alert

-4.05% News Effect

On the day this news was published, SCYRF declined 4.05%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") announces that it has granted 3,870,000 stock options (the "Options") to various employees, directors, officers and consultants of the Company.

Each Option is exercisable at a price of $0.12 for one common share of the Company (each a "Common Share") for a period of five years from the date of grant and are being issued under the terms of the Company's Omnibus Long-Term Incentive Plan. The Options, and any Common Shares issued upon exercise of the Options, are subject to a four-month and one day resale restriction from the date of grant under applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").

The aforementioned grant of Options resulted in certain directors and officers of the Company receiving an aggregate of 2,910,000 Stock Options. The Company has relied on the exemptions from the valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"), contained in section 5.5(b) and 5.7(a) of MI 61-101 in respect of such insider participation.

About Scryb
Scryb invests in and actively supports a growing portfolio of innovative and high-upside ventures across the technology sector.

Contact:
James Van Staveren, CEO
Phone: 647-847-5543
Email: info@scryb.ai

Forward-Looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to, delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at https://www.sedarplus.ca/.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268654

FAQ

How many stock options did Scryb (SCYRF) grant in October 2025?

Scryb granted a total of 3,870,000 stock options, with 2,910,000 options allocated to directors and officers.

What is the exercise price of Scryb's October 2025 stock options?

The stock options are exercisable at $0.12 per share for a period of five years from the grant date.

What are the restrictions on Scryb's newly granted stock options?

The options include a four-month and one-day resale restriction from the grant date under securities laws and CSE policies.

How many Scryb stock options were granted to insiders in October 2025?

2,910,000 stock options were granted to directors and officers of the company.